Company news
Trellus Health Plc (LSE:TRLS) news
Trellus Health Plc news releases on 6ix. Latest, Aug 12, 2026: Loan and Related Party Transaction
Press releases & updates
Loan and Related Party Transaction
August 12, 2026
Trellus Health
July 6, 2026
Delay to Publication of Annual Report and Accounts
June 30, 2026
Update
June 19, 2026
Suspension - Trellus Health Plc
May 8, 2026
Pfizer Licensing Agreement Renewal
April 13, 2026
Funding Update
April 2, 2026
MSA Signed and Funding Update
March 27, 2026
Issue of Equity - Conversion of Loan Notes
March 10, 2026
Contract Extension with Johnson & Johnson
February 18, 2026
Issue of Equity
February 11, 2026
Holding(s) in Company
February 6, 2026
Business update
February 3, 2026
Grant of Share Options
January 29, 2026
Result of Meeting
January 20, 2026
Proposed issue of Secured Convertible Loan Notes
December 30, 2025
Finance update
November 24, 2025
Contract signed with second leading CRO
November 7, 2025
Contract Signed with Leading Global CRO
October 22, 2025
Company Update
October 21, 2025
Interim results - Replacement
September 8, 2025
Interim results
September 8, 2025
Notice of Results
September 3, 2025
Result of AGM
July 1, 2025
AGM Statement
June 30, 2025
Posting of Annual Report and Notice of AGM
June 4, 2025
Final Results
June 2, 2025
Agreement with Johnson & Johnson
January 14, 2025
Change of Registered Office
December 27, 2024
Half-year Report
September 26, 2024
Directorate Change
September 19, 2024
Directorate Changes
June 7, 2024
Posting of Annual Report & Accounts & AGM Notice
May 20, 2024
Preliminary Results
April 23, 2024
Agreement with US Health Plan
February 28, 2024
Appointment of Chief Financial Officer
September 12, 2023
Related Party Transactions
June 13, 2023
Trading Update
March 6, 2023
Launch of D2C IBS Offering
February 17, 2023
New York Medicaid Health Plan Agreement
February 13, 2023
Trading Update & Related Party Transaction
December 20, 2022
Trellus IBD program launches on GI OnDEMAND
October 19, 2022
Two contracts signed with Mount Sinai
October 17, 2022
Second Price Monitoring Extn
October 5, 2022
Price Monitoring Extension
October 5, 2022
Marla Dubinsky a recipient of 2022 Sherman Prize
September 26, 2022
Notice of Results and Investor Presentation
September 22, 2022
Result of AGM and voting results
June 27, 2022
Posting of Annual Report & Accounts
May 25, 2022
Investor Presentation
May 10, 2022